Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response.
Fragment- and structure-based drug discovery for developing therapeutic agents targeting the DNA Damage Response. Prog Biophys Mol Biol. 2021 08; 163:130-142.